Report - Cetuximab plus weekly oxaliplatin/5FU/FA (FUFOX) in 1 st line metastatic gastric cancer. Final results from a multicenter phase II study of the AIO upper.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form